Amneal Pharmaceuticals is pleased to announce that it received U.S. FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneal’s generic is an AB-rated, therapeutically equivalent alternative to Ultracet® (a licensed trademark of Ortho-McNeil Janssen). U.S. sales of Tramadol/APAP were $61 MM according to June 2009 IMS Health market data. Continue Reading
Governments are under increasing pressure to provide access to expensive new drugs. Canadian patients who want access to drugs that are not publicly insured are seeking to pay for these drugs within public hospitals, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only). Continue Reading
The Wall Street Journal reports that insurers are bringing their insurance plans in compliance with new rules and laws that make mental health and substance abuse insurance coverage available to millions of Americans. Continue Reading
AmerisourceBergen announced a unique offering designed to help hospitals and health systems achieve meaningful use readiness for electronic health records (EHR), regardless of the technology they are using. Continue Reading
The Westaim Corporation (Westaim or the Company) (TSX: “WED”) announced today that, following the approval of the transaction by the shareholders of NUCRYST Pharmaceuticals Corp. (Nucryst), Westaim’s wholly-owned subsidiary, 1499642 Alberta Ltd. (1499642), amalgamated (the Amalgamation) with Nucryst to form a new company under the name “Westaim Holdings Limited” (Westaim Holdings). Continue Reading
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with Merck, through an affiliate, to develop novel antibody therapeutics to a specified disease target. Continue Reading
There are two months until the April 15 tax deadline, and if your family has experienced a decrease in income due to the economic downturn, you may now qualify for a low-cost nonprofit orthodontic program. Smiles Change Lives (SCL) is looking for kids from low-income families who need braces. Continue Reading
Stereotaxis today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located in Taipei. CHMC hosted a Grand Opening event on January 26 that received wide coverage throughout the area and, to date, ten procedures have been successfully performed using Stereotaxis at the hospital. Continue Reading
Ever get a buzz from eating chocolate? A study published in the open access journal BMC Neuroscience has shown that chocolate-craving mice are ready to tolerate electric shocks to get their fix. Continue Reading
Four leading national health professional associations have collectively recommended the adoption of the World Health Organization (WHO) Growth Charts for monitoring the growth of Canadian children in all primary health care and clinical settings. Continue Reading
